store at low temperature
store at -80°C
Theralizumab (TGN1412) is an anti-CD28-targeting monoclonal antibody that directly stimulates T cells. Theralizumab has antitumor activity and is used for the treatment of B-cell chronic lymphocytic leukemia and rheumatoid arthritis.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 933.00 | |
5 mg | In stock | $ 2,620.00 | |
10 mg | In stock | $ 4,190.00 |
Description | Theralizumab (TGN1412) is an anti-CD28-targeting monoclonal antibody that directly stimulates T cells. Theralizumab has antitumor activity and is used for the treatment of B-cell chronic lymphocytic leukemia and rheumatoid arthritis. |
Synonyms | TGN1412, TAB-08, TABO8 |
Molecular Weight | N/A |
CAS No. | 906068-56-2 |
store at low temperature
store at -80°C
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Theralizumab 906068-56-2 Others TABO 8 TGN1412 TAB 08 TGN-1412 TAB-08 TABO8 TABO-8 TGN 1412 TAB08 inhibitor inhibit